NASDAQ:ESTA

Establishment Labs Stock Forecast, Price & News

$70.53
-2.17 (-2.98 %)
(As of 09/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$70.02
$74.26
50-Day Range
$67.01
$79.94
52-Week Range
$16.50
$88.66
Volume92,771 shs
Average Volume102,673 shs
Market Capitalization$1.67 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.06
30 days | 90 days | 365 days | Advanced Chart
Receive ESTA News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.


Establishment Labs logo

About Establishment Labs

Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It operates through the following geographical segments: Europe, Latin America, Asia Pacific and Middle East, and Other. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Divina, and Puregraft. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.15 out of 5 stars

Medical Sector

406th out of 1,352 stocks

Surgical Appliances & Supplies Industry

13th out of 26 stocks

Analyst Opinion: 2.4Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Establishment Labs (NASDAQ:ESTA) Frequently Asked Questions

Is Establishment Labs a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Establishment Labs stock.
View analyst ratings for Establishment Labs
or view top-rated stocks.

What stocks does MarketBeat like better than Establishment Labs?

Wall Street analysts have given Establishment Labs a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Establishment Labs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Establishment Labs' next earnings date?

Establishment Labs is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for Establishment Labs
.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) issued its quarterly earnings results on Thursday, July, 29th. The company reported ($0.22) EPS for the quarter, topping analysts' consensus estimates of ($0.28) by $0.06. The firm had revenue of $31.99 million for the quarter, compared to the consensus estimate of $31.50 million. Establishment Labs had a negative net margin of 19.78% and a negative trailing twelve-month return on equity of 29.92%.
View Establishment Labs' earnings history
.

How has Establishment Labs' stock price been impacted by Coronavirus (COVID-19)?

Establishment Labs' stock was trading at $15.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ESTA shares have increased by 365.5% and is now trading at $70.53.
View which stocks have been most impacted by COVID-19
.

What guidance has Establishment Labs issued on next quarter's earnings?

Establishment Labs issued an update on its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $122 million-$126 million, compared to the consensus revenue estimate of $120.91 million.

What price target have analysts set for ESTA?

4 brokerages have issued 12-month price objectives for Establishment Labs' stock. Their forecasts range from $78.00 to $90.00. On average, they expect Establishment Labs' stock price to reach $84.50 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price.
View analysts' price targets for Establishment Labs
or view top-rated stocks among Wall Street analysts.

Who are Establishment Labs' key executives?

Establishment Labs' management team includes the following people:
  • Juan José Chacón Quirós, Chief Executive Officer & Director
  • Pratip Dastidar, Global Head-Operations
  • Raj Denhoy, Chief Financial Officer
  • Roberto de Mezerville, Chief Technology Officer
  • Olivier Tourniaire, VP-Sales Asia Pacific, Middle East & Africa

Who are some of Establishment Labs' key competitors?

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

When did Establishment Labs IPO?

(ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager.

What is Establishment Labs' stock symbol?

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Who are Establishment Labs' major shareholders?

Establishment Labs' stock is owned by many different retail and institutional investors. Top institutional shareholders include Nantahala Capital Management LLC (8.12%), Perceptive Advisors LLC (2.95%), Perceptive Advisors LLC (2.95%), Nicholas Investment Partners LP (0.99%), Kornitzer Capital Management Inc. KS (0.77%) and Citadel Advisors LLC (0.00%). Company insiders that own Establishment Labs stock include Dennis E Condon, Dennis E Condon, Jw Asset Management, Llc, Lisa Gersh, Mezerville Roberto De, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Renee Gaeta and Santos Salvador Dada.
View institutional ownership trends for Establishment Labs
.

Which institutional investors are selling Establishment Labs stock?

ESTA stock was sold by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Perceptive Advisors LLC, Nantahala Capital Management LLC, Tygh Capital Management Inc., Morgan Stanley, Morgan Stanley, Cambridge Investment Research Advisors Inc., and Rice Hall James & Associates LLC. Company insiders that have sold Establishment Labs company stock in the last year include Dennis E Condon, Lisa Gersh, Mezerville Roberto De, Quiros Juan Jose Chacon, Renee Gaeta, and Santos Salvador Dada.
View insider buying and selling activity for Establishment Labs
or view top insider-selling stocks.

Which institutional investors are buying Establishment Labs stock?

ESTA stock was bought by a variety of institutional investors in the last quarter, including Nicholas Investment Partners LP, Allianz Asset Management GmbH, BlackRock Inc., Swiss National Bank, Millennium Management LLC, Landsberg Bennett & Dubbaneh LLC, Calamos Advisors LLC, and Renaissance Technologies LLC. Company insiders that have bought Establishment Labs stock in the last two years include Jw Asset Management, Llc, Mezerville Roberto De, and Nicholas Sheridan Lewin.
View insider buying and selling activity for Establishment Labs
or or view top insider-buying stocks.

How do I buy shares of Establishment Labs?

Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Establishment Labs' stock price today?

One share of ESTA stock can currently be purchased for approximately $70.53.

How much money does Establishment Labs make?

Establishment Labs has a market capitalization of $1.67 billion and generates $84.68 million in revenue each year. The company earns $-38,120,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis.

How many employees does Establishment Labs have?

Establishment Labs employs 521 workers across the globe.

What is Establishment Labs' official website?

The official website for Establishment Labs is www.establishmentlabs.com.

Where are Establishment Labs' headquarters?

Establishment Labs is headquartered at Building B15 and 25 Coyol Free Zone, Alajuela G2, .

How can I contact Establishment Labs?

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at (062) 434-2400 or via email at [email protected].


This page was last updated on 9/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.